Blog - Announcements

Vaso Corporation to Report Year 2016 Results on March 30, 2017

  March 23, 2017   By Admin

Management to Hold Investor Conference Call on March 30, 2017 at 10:00 a.m. ET

PLAINVIEW, NY / ACCESSWIRE / March 23, 2017 / Vaso Corporation (OTC PINK: VASO) announced today that it will release its financial results for the year ended December 31, 2016 on Thursday, March 30, 2017, before market open.

The Company will host a conference call on Thursday, March 30, 2017 at 10:00 a.m. eastern time, featuring presentations by Jun Ma, Ph.D., President and CEO, Peter Castle, Chief Operating Officer, and Michael Beecher, Chief Financial Officer of Vaso. To join the conference call, please dial 1-877-407-8033 from the U.S. or 1-201-689-8033, internationally. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vaso Corporation’s website, Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available at approximately two hours after completion of the live conference call. To access the replay of the call, which will be available until April 30, 2017, please dial 1-877-481-4010 or international 1-919-882-2331, and use the code 10295.

About Vaso Corporation

Vaso Corporation is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products and healthcare software solutions, as well as in the provision of managed network services. The Company conducts its business through four wholly owned subsidiaries, as follows: Vaso Technology, Inc. provides network and IT services through two business units: VasoHealthcare IT Corp., a national value added reseller of GE Healthcare IT’s Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support, and NetWolves Network Services LLC, a managed network services provider with an extensive proprietary service platform to a broad base of customers; Vaso Diagnostics, Inc. d.b.a. VasoHealthcare provides professional sales services and is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Vasomedical Solutions, Inc. manages and coordinates the design, manufacture and sales of EECP┬« Therapy systems and other medical equipment operations; and Vasomedical Global Corp., which operates the Company’s China-based subsidiaries. Additional information is available on the Company’s website at

Investor Contacts:

Michael Beecher
Investor Relations

SOURCE: Vasomedical, Inc.

DISCLAIMER: Please note the date of the release appears in real time and will automatically update as your release crosses the wires. To make changes or to schedule your release for distribution please email or call our News Desk Team at 919.481.4000. If there is a problem with your news distribution, please note that Issuer Direct must be contacted no more than 90 minutes after your intended cross time in order to be of assistance. Any correspondence received outside of this timeframe will be dealt with at the discretion of management. Per our corporate policy, this release will not be made public without your direct approval.